NLC closes Momentum, provides funding support for MLA Diagnostics
NLC The European Healthtech Venture Builder has closed Momentum – a € 2.2 mln fund for private investments -within a month. This fund will be invested in 11 innovative healthtech ventures from NLC’s portfolio. With this new way of funding, investors can easily spread their money and hence their risk, and at the same time build […]
MLA Diagnostics is awarded a LBDF POP subsidy by LIOF
The LBDF POP grant will support a Health Technology Assessment project in collaboration with Clinical Epidemiology & Medical Technology Assessment (KEMTA) and HI-NL. The project consisted of 3 phases: patient journey inventory, health economic modelling and an expert round table session including experts from all domains (clinical, insurance, reimbursement, regulatory, health economic and clinical methodology).